- Raised $12.8M grant, Feb 2017
- Raised $10M funding round, Dec 2015
- Raised $2.4M grant, Nov 2014
About
Orgenesis is a pioneering global biotech company featuring a unique Cell & Gene Therapy Biotech Platform. The company is focused on unlocking the power of cell and gene therapies with this platform to provide life changing treatments at the Point of Care (POCare) to large numbers of patients at drastically reduced costs.
The Platform consists of a pipeline of POCare Therapeutics; a suite of hand-selected and customized POCare Technologies for closed processing; and a collaborative, global POCare Network of leading companies, research institutes and hospitals. Working with this Platform, Orgenesis leverages cutting edge science to create a more efficient, scalable, and affordable pathway to patients.
In June 2019, Orgenesis was granted an FDA orphan drug designation for its autologous insulin-producing cells.
Funding history · 4 rounds · $18.2M total
Q&A
- What is Orgenesis' primary focus?
- Orgenesis is a global biotech company focused on unlocking the power of cell and gene therapies through its unique Cell & Gene Therapy Biotech Platform to provide life-changing treatments at the Point of Care (POCare).
- When was Orgenesis founded?
- Orgenesis was founded in January 2008.
- What is the employee count for Orgenesis?
- Orgenesis has 11-50 employees.
- What is Orgenesis' current status?
- Orgenesis is currently public on NASDAQ, as of March 2018.
- What was the most recent funding round for Orgenesis?
- Orgenesis received a Grant in February 2017 for $12,800,000 from Service Public of Wallonia, DGO6.
- Has Orgenesis received any orphan drug designations?
- In June 2019, Orgenesis was granted an FDA orphan drug designation for its autologous insulin-producing cells.
- What is Orgenesis' total amount raised in funding?
- Orgenesis has raised a total of $18,200,000.
- Where is Orgenesis headquartered?
- Orgenesis is headquartered in Ness Ziona, Israel.
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/6112356 | |
| facebook.com/Orgenesis-Inc-101879208270597 | |
| YouTube | youtube.com/channel/UCMyvWvSUuJt0Hvmis-EIrhg |
Identifiers & details
| Founded | 2008-1 |
|---|---|
| Employees (exact) | 48 |
| Offices | Germantown |
| Market cap | $776K |
| Status reason | Public on NASDAQ on Mar, 2018; |
Radar intelligence
Patents
| EPO | 33 |
|---|
Publications (Crossref)
| Works | 10 |
|---|